Recent concerns on whether Denmark is properly protected in terms of access to vaccines have been implemented in the new national Danish life science strategy which was presented early Friday. The strategy mentions partnerships with the life science industry to strengthen vaccine access.
According to the WHO, Denmark is looking into the possibility of sharing its doses of the Astrazeneca vaccine with developing countries after the vaccine has been discontinued in the Danish vaccine program.
The EMA has announced that it sees a possible connection between Astrazeneca's Covid-19 vaccine and some highly rare cases of blood clots following vaccinations, but it maintains its recommendations to keep using the vaccine.
Insulin producers Novo Nordisk, Sanofi and Eli Lilly have come under attack from Democratic Party representatives in the US who have encouraged the US Federal Trade Commission to investigate them for potential collusion in the US insulin market.
Following 'thorough investigations' the Danish Competition and Consumer Authority has approved that Orifarm can take over a range of drugs and factories from Japanese Takeda. However, in return, the firm has to divest several products and rights.